首页 › 基金 › Parkman Healthcare Partners LLC › SRRK

Parkman Healthcare Partners LLC 对 SRRK 的持仓历史

SCHOLAR ROCK HLDG CORP · 医疗保健

Parkman Healthcare Partners LLC 在 Q3 2026 的 13F 申报中披露持有 SRRK(SCHOLAR ROCK HLDG CORP)540,000 股,市值约 US$26.1M,约占其申报组合的 2.36%,在其申报持仓中市值排名第 9 位。 Parkman Healthcare Partners LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)540.00K 股
申报持仓市值$26.09M
组合权重2.36%
首次申报Q3 2026
最近变动新进
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Parkman Healthcare Partners LLC 对 SRRK 的持仓演变

Parkman Healthcare Partners LLC 于 Q3 2026 首次披露 SRRK 持仓:540,000 股(约 US$26.1M)。

逐季持仓明细

季度股数金额变化
Q3 2026 540.00K $26.09M 新进

关于 SRRK 与 13F 数据

SRRK(SCHOLAR ROCK HLDG CORP)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 SRRK,申报仓位最大的包括:Siren, L.L.C. (US$453.0M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$293.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SRRK 的基金

查看 SRRK 的全部基金持有人 →

常见问题

How long has Parkman Healthcare Partners LLC held SRRK?

Parkman Healthcare Partners LLC has disclosed SRRK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Parkman Healthcare Partners LLC's current position in SRRK?

As of Q3 2026, Parkman Healthcare Partners LLC holds 540.00K shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $26.09M, representing 2.36% of its reported portfolio and ranking #9.

Has Parkman Healthcare Partners LLC been buying or selling SRRK?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC newly opened its position in SRRK.

Which other funds hold SRRK?

Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.